Cancer and Noncoding RNAs
Published on 13. October 2017
576 pages
978-0-12-813437-5 (ISBN)
Description
Cancer and Noncoding RNAs offers an in-depth exploration of noncoding RNAs and their role in epigenetic regulation of complex human disease, most notably cancer. In addition to examining microRNAs, this volume provides a unique evaluation of more recently profiled noncoding RNAs now implicated in carcinogenesis, including lncRNAs, piRNAs, circRNAs, and tRNAs, identifying differences in function between these noncoding RNAs and how they interact with the rest of the epigenome. A broad range of chapters from experts in the field detail epigenetic regulation of various cancer types, along with recent next generation sequencing technologies, genome-wide association studies (GWAS) and bioinformatics approaches.
This book will help researchers in genomic medicine and cancer biology better understand the role of noncoding RNAs in epigenetics, aiding in the development of useful biomarkers for diagnosis, prognosis and new RNA-based disease therapies.
- Provides a comprehensive analysis of noncoding RNAs implicated in epigenetic regulation of gene expression and chromatin dynamics
- Educates researchers and graduate students by highlighting, in addition to miRNAs, a range of noncoding RNAs newly associated with carcinogenesis
- Applies current knowledge of noncoding RNAs and epigenomics towards developing cancer and RNA-based disease therapies
- Features contributions by leading experts in the field
More details
Other editions
Additional editions
Book
10/2017
Academic Press
€184.50
Shipment within 15-20 days
Content
1. Introduction
SECTION I: NON-CODING RNAs: FINE-TUNING CANCER2. miRNA and Cancer: A Deadly Liaison?3. Alteration of MicroRNA Biogenesis Pathways in Cancers4. MicroRNAs In Exosomes in Cancer5. Circulating miRNAs Incresaing the Risk of Cancer6. Long Noncoding RNAs as Cancer Biomarkers7. The Balancing Act: Understanding MicroRNA and Competing Endogenous RNA Regulation in Cancer8. PIWI-Interacting RNAs (piRNAs) and Cancer9. Transfer RNA in Cancer10. Dynamic Regulation of tRNA Modifications in Cancer11. Circular RNA: A Novel Noncoding RNA in Cancer12. Antisense RNA and Cancer13. Implication of Other Noncoding RNAs in Cancer
SECTION 2: GENETIC DYSREGULATION OF NON-CODING RNA IN CANCER14. Noncoding RNA Alterations in Cancer Molecular Pathways15. Genetic Alteration of MicroRNA Affecting Cancer Pathways16. Genetic Variations of Long Noncoding RNAs in Cancer
SECTION 3: EPIGENETIC EFFECT ON CANCER THROUGH NON-CODING RNAs17. Cross Talk Between Noncoding RNAs and DNA Methylation and Demethylation in Cancer18. Noncoding RNAs Act as a Chromatin Scaffold of Histone Modification Complexes in Cancer19. Heterochromatin Modulation and PcG Control of Gene Expression Medicated by Noncoding RNA in Cancer20. Epigenetic Control of MicroRNA Expression and Cancer21. Implications of Long Noncoding RNAs in Cancer Epigenetics
SECTION 4: THERAPEUTIC IMPLICATIONS OF NON-CODING RNA IN CANCER22. Long Noncoding RNAs: Insight Into Their Roles in Normal and Cancer Stem Cells23. Clinical Relevance, Prognostic Potential, and Therapeutic Strategies of Noncoding RNAs in Cancer24. Noncoding RNAs: Novel Targets in Anticancer Drug Development
SECTION 5: BIOINFORMATICS' DETECTION OF NON-CODING RNA IN CANCER25. Cancer Noncoding RNA Discovery Through High-Throughput Sequencing26. Noncoding RNAs as a Cauce of Cancer: Evidence From Genome-Wide Association Studies and Reverse Genetics27. A Comparative Evaluation of Emerging Databases and Tools for Cancer Noncoding RNAs28. Future Directions and Challenges Involved in Cancer Noncoding RNomics
